Evaluation of medication adherence in Lebanese hypertensive patients

Yassine, Mohammad; Al‐Hajje, Amal; Awada, Sanaa; Rachidi, Samar; Zein, Sharif Hussein Sharif; Bawab, Wafaa; Zeid, Mayssam Bou; Hajj, Maya El; Salameh, Pascale

doi:10.1016/j.jegh.2015.07.002

Cited by 44 publications

(43 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…We performed meta-analyses for studies using the eight-item Morisky Medication Adherence Scale (MMAS) 10,[16][17][18][19][20] and the 80 and 90% cut-off scales, 11,12,[21][22][23] as the majority of the studies used those methods. The meta-analyses were done separately, as we did not find them comparable according to the measurement of non-adherence being used (detailed questions vs pill counting).…”

Section: Discussionmentioning

confidence: 99%

“…[9][10][11][12][16][17][18][19][20][21][22][23][28][29][30][31][32][33][34][35][36][37] The majority of these studies were from China Nigeria and Malaysia (Table 1). …”

Section: Study Selectionmentioning

confidence: 99%

“…Different ways of reporting knowledge and aOR were: knowledge of hypertension and treatment with an aOR at 0.16 (CI: 0.08-0.31), 9 knowing normal BP level with an aOR at 0.2 (CI: 0.06-0.66), 18 knowing perceptions of benefits with an aOR at 0.81 (CI: 0.72-0.90) and knowing perceptions of susceptibility with an aOR at and 1.43 (CI: 1,14-1,79). 22 These aORs show that being more knowledgeable lowers the odds of being non-adherent, with the exception of 'knowing perceptions of susceptibility', which according to this single study raises odds of being non-adherent.…”

Section: Study Characteristicsmentioning

confidence: 99%

“…(3) Conditions-related factors Comorbidity, 9,29 BP level control, 9,11,22 taking calcium channel blokers, 18 Non-adherence to anti-hypertensive medication in low-and middle-income countries JØ Nielsen et al affecting non-adherence. Older age resulted in higher adherence and being a woman, having a controlled BP and being knowledgeable is also in one way or another correlated with an increased likelihood of being adherent.…”

mentioning

confidence: 99%

See 3 more Smart Citations

Non-adherence to anti-hypertensive medication in low- and middle-income countries: a systematic review and meta-analysis of 92443 subjects

Nielsen¹,

Shrestha

Neupane³

et al. 2016

J Hum Hypertens

122

117

View full text Add to dashboard Cite

Hypertension is a rising global burden, and low- and middle-income countries account for 80% of deaths due to complications of hypertension. Hypertension can be controlled by adhering to anti-hypertensive medication. However, non-adherence is an increasing challenge. This review aims to systematically evaluate non-adherence to anti-hypertensive medication among adults in low- and middle-income countries and explore factors affecting non-adherence to anti-hypertensive medication. We performed a systematic search for studies published between 1 January 2000 and 31 August 2015. A selection process was performed for data extraction with a combination of Medical Subject Headings terms: 'hypertension' and 'adherence'. Further search criteria were: language ('english'), species ('humans'), and low- and middle-income countries. A total of 22 studies met the inclusion criteria. The pooled percentage of non-adherence when using the eight-item Morisky Medication Adherence Scale (MMAS) was 63.35% (confidence of interval (CI): 38.78-87.91) and 25.45% (CI:17.23-33.76) when using the 80 and 90% cut-off scales. The factors were classified into the five dimensions of adherence defined by the World Health Organization, and the majority of the studies reported factors from the dimension 'social and economic factors'. This systematic review demonstrated considerable variation of non-adherence to anti-hypertensive medication in low- and middle-income countries depending on the methods used to estimate non-adherence. The results showed a high non-adherence when the MMAS eight-item scale was used and low when the 80 and 90% cut-off scales were used. The majority of factors affecting non-adherence to anti-hypertensive medication fell within the World Health Organization defined dimension 'social and economic factors'.

show abstract

Section: Discussionmentioning

confidence: 99%

“…[9][10][11][12][16][17][18][19][20][21][22][23][28][29][30][31][32][33][34][35][36][37] The majority of these studies were from China Nigeria and Malaysia (Table 1). …”

Section: Study Selectionmentioning

confidence: 99%

Section: Study Characteristicsmentioning

confidence: 99%

mentioning

confidence: 99%

See 2 more Smart Citations

Non-adherence to anti-hypertensive medication in low- and middle-income countries: a systematic review and meta-analysis of 92443 subjects

Nielsen¹,

Shrestha

Neupane³

et al. 2016

J Hum Hypertens

122

117

View full text Add to dashboard Cite

show abstract

“…En relación con la edad y el sexo, en este estudio no se encontraron diferencias en el nivel de adherencia al estratificar por estas condiciones, a diferencia de lo reportado en la literatura en donde se refiere que los hombres con menor edad y menor tiempo con la enfermedad tienden a tener una menor adherencia; algunos destacan que por cada 10 años con el proceso de enfermedad la adherencia aumenta, siendo los 60 años o más donde hay mejor cumplimiento[29][30][31][32][33] . A pesar de los resultados de nuestro estudio, consideramos que estas variables deben ser tenidas en cuenta al momento de brindar educación y de implementar estrategias para aumentar la adherencia en este tipo de población.Dentro de las fortalezas de este estudio resaltamos la medición de aspectos más allá del abordaje farmacológico del régimen terapéutico en personas con HTA y DM tipo 2, incluyendo indicadores relacionados con la dieta, ejercicio, control de conductas que potencian la patología, supervisión del estado de enfermedad, efectos terapéuticos entre otros.…”

unclassified

Adherencia terapéutica de pacientes con hipertensión arterial y diabetes mellitus tipo 2 de Bucaramanga, Colombia

Romero

Parra

Sánchez

et al. 2017

revsal

View full text Add to dashboard Cite

show abstract

Assessment of patients’ knowledge and practices regarding their medication use and risks in Lebanon

et al. 2017

View full text Add to dashboard Cite

Background Patients' knowledge of their medications play a pivotal role in their disease management. Objective Assess the knowledge and practices of Lebanese outpatients regarding their own medication use and risks. Setting Four hundred and sixty community pharmacies across Lebanon. Method It was a cross-sectional study performed from March through May 2016 among Lebanese outpatients, using a self-administered questionnaire. Descriptive statistics were used to calculate all participants' responses. The association between categorical variables were evaluated using Pearson χ test or Fisher's exact test. Binary logistic regressions were performed to identify factors associated with medication patients' knowledge and interest. Main outcome measure Ability of the patients to identify own medications' elements: name, strength, dosage regimen, indication, and adverse drug reactions. Results Our study comprised 921 patients, with around 16% taking ≥5 medications/day. Around 56% of our patients showed sub-optimal medication knowledge. Patients' higher educational level, number of chronic diseases, and patient physician interaction were associated with higher medication knowledge. Many patients admitted not discussing their medications each time they visit their physicians (38.7%); not reading the leaflet of each medication they take (61.2%); and not regularly asking their pharmacist about the potential interactions of OTC drugs with prescribed medications (53.9%). Conclusion This study showed suboptimal medication-related knowledge, and suboptimal patient's interactions with primary care givers. Our findings serve as a platform for healthcare providers to understand patients' needs and educate them about medication use and risks.

show abstract

Evaluation of medication adherence in Lebanese hypertensive patients

Cited by 44 publications

References 31 publications

Non-adherence to anti-hypertensive medication in low- and middle-income countries: a systematic review and meta-analysis of 92443 subjects

Non-adherence to anti-hypertensive medication in low- and middle-income countries: a systematic review and meta-analysis of 92443 subjects

Adherencia terapéutica de pacientes con hipertensión arterial y diabetes mellitus tipo 2 de Bucaramanga, Colombia

Assessment of patients’ knowledge and practices regarding their medication use and risks in Lebanon

Contact Info

Product

Resources

About